CNTBConnect Biopharma Holdings Ltd - ADR
CNTB
Connect Biopharma Holdings Ltd - ADR781
Mkt Cap
$133.39MVolume
20,047.0052W High
$3.8252W Low
$0.70PE Ratio
-2.37CNTB Fundamentals
Price
$2.37Prev Close
$2.36Open
$2.3750D MA
$2.73Beta
0.60Avg. Volume
359,361.52EPS (Annual)
-$0.9968P/B
3.17Rev/Employee
$1,000.00$113.31
BML Capital Management LLC Sells 858,613 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB
BML Capital Management LLC lowered its holdings in shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) by 67.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owne...
MarketBeat·5d ago
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts
Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assig...
MarketBeat·11d ago
Northland Securities Weighs in on CNTB Q1 Earnings
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Equities research analysts at Northland Securities issued their Q1 2026 earnings per share (EPS) estimates for Connect...
MarketBeat·14d ago
Q1 Earnings Estimate for CNTB Issued By HC Wainwright
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Connect Biopharma in a research note issued on Wednesday, April 8th. HC Wainwright analyst B. Folkes expects that the company will post...
MarketBeat·1mo ago
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts
Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the five ratings firms that are currently...
MarketBeat·1mo ago
Connect Biopharma (NASDAQ:CNTB) Director Buys $4,002,000.00 in Stock
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) Director James Huang acquired 1,160,000 shares of Connect Biopharma stock in a transaction that occurred on Tuesday...
MarketBeat·1mo ago
Connect Biopharma (NASDAQ:CNTB) Director James Huang Acquires 1,160,000 Shares
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) Director James Huang bought 1,160,000 shares of the stock in a transaction on Tuesday, March 31st. The stock was purchased at an average cost of $3.45 per share, with a total value of $4,002,000.00. Following the...
MarketBeat·1mo ago
Connect Biopharma (NASDAQ:CNTB) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS
Connect Biopharma (NASDAQ:CNTB - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.27) earnings per share for the quarter, topping analysts' consensus estimates of...
MarketBeat·1mo ago
Connect Biopharma (NASDAQ:CNTB) Receives "Buy" Rating from BTIG Research
BTIG Research restated a "buy" rating and issued a $10.00 price target on shares of Connect Biopharma in a research report on Tuesday...
MarketBeat·1mo ago
Connect Biopharma touts rapid IV rademikibart FEV1 gains; Phase 3 atopic dermatitis data impresses
Connect Biopharma (NASDAQ:CNTB) shared new clinical and preclinical updates on rademikibart, its IL-4 receptor alpha monoclonal antibody, highlighting preliminary top-line results from an intravenous...
MarketBeat·1mo ago
<
1
2
...
>